Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.

dc.contributor.authorPérez-Hernández, Marta
dc.contributor.authorNieto Marín, Paloma
dc.contributor.authorCrespo García, María Teresa
dc.contributor.authorTamargo Menéndez, Juan
dc.contributor.authorCaballero Collado, Ricardo
dc.contributor.authorDelpón Mosquera, María Eva
dc.date.accessioned2024-01-09T17:10:47Z
dc.date.available2024-01-09T17:10:47Z
dc.date.issued2018
dc.description.abstractCardiac Nav1.5 and Kir2.1–2.3 channels generate Na (INa) and inward rectifier K (IK1) currents, respectively. The functional INa and IK1 interplay is reinforced by the positive and reciprocal modulation between Nav15 and Kir2.1/2.2 channels to strengthen the control of ventricular excitability. Loss-of-function mutations in the SCN5A gene, which encodes Nav1.5 channels, underlie several inherited arrhythmogenic syndromes, including Brugada syndrome (BrS). We investigated whether the presence of BrS-associated mutations alters IK1 density concomitantly with INa density. Results obtained using mouse models of SCN5A haploinsufficiency, and the overexpression of native and mutated Nav1.5 channels in expression systems — rat ventricular cardiomyocytes and human induced pluripotent stem cell–derived cardiomyocytes (hiPSC-CMs) — demonstrated that endoplasmic reticulum (ER) trafficking–defective Nav1.5 channels significantly decreased IK1, since they did not positively modulate Kir2.1/2.2 channels. Moreover, Golgi trafficking–defective Nav1.5 mutants produced a dominant negative effect on Kir2.1/2.2 and thus an additional IK1 reduction. Moreover, ER trafficking–defective Nav1.5 channels can be partially rescued by Kir2.1/2.2 channels through an unconventional secretory route that involves Golgi reassembly stacking proteins (GRASPs). Therefore, cardiac excitability would be greatly affected in subjects harboring Nav1.5 mutations with Golgi trafficking defects, since these mutants can concomitantly trap Kir2.1/2.2 channels, thus unexpectedly decreasing IK1 in addition to INa.
dc.description.departmentDepto. de Farmacología y Toxicología
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipComunidad de Madrid
dc.description.sponsorshipEuropean Commission
dc.description.sponsorshipMinisterio de Economía y Competitividad (España)
dc.description.sponsorshipInstituto de Salud Carlos III
dc.description.sponsorshipFundación BBVA
dc.description.sponsorshipLeducq foundation
dc.description.statuspub
dc.identifier.citationJCI Insight. 2018;3(18):e96291. https://doi.org/10.1172/jci.insight.96291.
dc.identifier.doi10.1172/jci.insight.96291
dc.identifier.essn2379-3708
dc.identifier.officialurlhttps://doi.org/10.1172/jci.insight.96291
dc.identifier.urihttps://hdl.handle.net/20.500.14352/92119
dc.issue.number18
dc.journal.titleJCI insight
dc.language.isoeng
dc.publisherAmerican Society for Clinical Investigation
dc.rights.accessRightsrestricted access
dc.subject.cdu61
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco32 Ciencias Médicas
dc.titleBrugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number3
dspace.entity.typePublication
relation.isAuthorOfPublication6fcddc0f-1c0a-4708-9d0a-ac61e0d09312
relation.isAuthorOfPublication6c810617-8ea2-4dfa-a8fc-9248e7a34df3
relation.isAuthorOfPublication22eeb834-bbe3-48f1-a140-d26c5bd0cdd6
relation.isAuthorOfPublication40b81dbc-a87f-4b7d-982a-db1ecdcdf07b
relation.isAuthorOfPublication36742207-526a-45e6-b33e-e711e180a5f9
relation.isAuthorOfPublication.latestForDiscovery6fcddc0f-1c0a-4708-9d0a-ac61e0d09312

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Brugada_syndrome.pdf
Size:
2.09 MB
Format:
Adobe Portable Document Format

Collections